Cost-effectiveness of trifluridine/tipiracil for previously treated metastatic colorectal cancer in England and Wales

Bullement, A. orcid.org/0000-0001-7091-0972, Underhill, S., Fougeray, R. et al. (1 more author) (2018) Cost-effectiveness of trifluridine/tipiracil for previously treated metastatic colorectal cancer in England and Wales. Clinical Colorectal Cancer, 17 (1). e143-e151. ISSN 1533-0028

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Cost-utility; Economic model; mCRC; NICE; TAS-102
Dates:
  • Accepted: 20 September 2017
  • Published (online): 28 September 2017
  • Published: March 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 12 Jan 2021 15:36
Last Modified: 12 Jan 2021 15:36
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.clcc.2017.09.001
Related URLs:

Share / Export

Statistics